The $4,500 injection to stop heroin overdoses image

Washington Post, January 27, 2017
Shefali Luthra, quoting W. Nicholson Price II (Academic Fellow Alumnus)


Read the full article

From the article:

Thanks to an infusion of public funding to combat opioid overdoses, other institutional buyers may also be able to afford Evzios. Their budgets are larger right now, so they’re less price sensitive, said Nicholson Price, an assistant professor at the University of Michigan Law School.

But that money comes from somewhere — most probably taxpayers. And it’s hardly sustainable, Price noted, saying “at some point in time, the rubber’s got to hit the road.”


Read more here!

bioethics fda health law policy pharmaceuticals w. nicholson price ii